1
|
Ahmed SS, Youssef AO, Mohamed EH, Attia MS. A highly selective optical sensor Eu-BINAM for assessment of high sensitivity cardiac troponin tumor marker in serum of cancer patients. SPECTROCHIMICA ACTA. PART A, MOLECULAR AND BIOMOLECULAR SPECTROSCOPY 2023; 300:122887. [PMID: 37224630 DOI: 10.1016/j.saa.2023.122887] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/09/2023] [Revised: 05/12/2023] [Accepted: 05/13/2023] [Indexed: 05/26/2023]
Abstract
A novel, easy, touchy and selective spectrofluorimetric technique has been successfully applied for sensitive determination of High Sensitivity Cardiac Troponin (TNHS I) in the serum samples of patients suffering malignant tumors through the usage of optical sensor Eu3+-BINAM complex. The technique is primarily based on quenching of the Eu3+-BINAM complex's luminescence intensity upon introducing various concentrations of High Sensitivity Cardiac Troponin (TNHS I). The synthesis and characterization of the optical sensor was performed via absorption and emission. The sensor was also adapted to offer excitation at 394 nm in acetonitrile at pH 7.5. Concentration of High Sensitivity Cardiac Troponin (TNHS I) in serum samples was found to be proportional to the luminescence intensity quenching of the Eu3+-BINAM complex, most prominently at λem = 618 nm. The limit of the dynamic range is 4.26 × 10-4 to 2 ng/mL. The limit of detection and quantitation were calculated to be 1.35 and 4.10 ng/mL, respectively. The suggested analytical approach proved its applicability, simplicity and comparatively interference- free. The technique was effectively recruited to quantify High Sensitivity Cardiac Troponin (TNHS I) in human serum samples. The proposed technique could be further extended to evaluate some biomarkers associated with malignancy related diseases in human.
Collapse
Affiliation(s)
- Shahenda S Ahmed
- Analytical Chemistry Department, Faculty of Science, Ain Shams University, Cairo, Egypt
| | - Ahmed O Youssef
- Analytical Chemistry Department, Faculty of Science, Ain Shams University, Cairo, Egypt
| | - Ekram H Mohamed
- Pharmaceutical Chemistry Department, Faculty of Pharmacy, British University, Cairo, Egypt
| | - Mohamed S Attia
- Analytical Chemistry Department, Faculty of Science, Ain Shams University, Cairo, Egypt
| |
Collapse
|
2
|
Choi JH, Fremy G, Charnay T, Fayad N, Pécaut J, Erbek S, Hildebrandt N, Martel-Frachet V, Grichine A, Sénèque O. Luminescent Peptide/Lanthanide(III) Complex Conjugates with Push–Pull Antennas: Application to One- and Two-Photon Microscopy Imaging. Inorg Chem 2022; 61:20674-20689. [DOI: 10.1021/acs.inorgchem.2c03646] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Affiliation(s)
- Ji-Hyung Choi
- Université Grenoble Alpes, CNRS, CEA, IRIG, LCBM (UMR 5249), Grenoble F-38000, France
| | - Guillaume Fremy
- Université Grenoble Alpes, CNRS, CEA, IRIG, LCBM (UMR 5249), Grenoble F-38000, France
- Université Grenoble Alpes, CNRS, DCM (UMR 5250), Grenoble F-38000, France
| | - Thibault Charnay
- Université Grenoble Alpes, CNRS, CEA, IRIG, LCBM (UMR 5249), Grenoble F-38000, France
| | - Nour Fayad
- Laboratoire COBRA (Chimie Organique, Bioorganique, Réactivite et Analyse), UMR 6014, CNRS, Université de Rouen Normandie, INSA, Mont-Saint-Aignan Cedex 76821, France
| | - Jacques Pécaut
- Université Grenoble Alpes, CEA, CNRS, IRIG, SyMMES, Grenoble F-38000, France
| | - Sule Erbek
- Institute for Advanced Biosciences, Université Grenoble Alpes, INSERM U1209, CNRS UMR 5309, Grenoble F-38000, France
- EPHE, PSL Research University, 4-14 Rue Ferrus, Paris 75014, France
| | - Niko Hildebrandt
- Laboratoire COBRA (Chimie Organique, Bioorganique, Réactivite et Analyse), UMR 6014, CNRS, Université de Rouen Normandie, INSA, Mont-Saint-Aignan Cedex 76821, France
| | - Véronique Martel-Frachet
- Institute for Advanced Biosciences, Université Grenoble Alpes, INSERM U1209, CNRS UMR 5309, Grenoble F-38000, France
- EPHE, PSL Research University, 4-14 Rue Ferrus, Paris 75014, France
| | - Alexei Grichine
- Institute for Advanced Biosciences, Université Grenoble Alpes, INSERM U1209, CNRS UMR 5309, Grenoble F-38000, France
| | - Olivier Sénèque
- Université Grenoble Alpes, CNRS, CEA, IRIG, LCBM (UMR 5249), Grenoble F-38000, France
| |
Collapse
|
3
|
Gorman D, Li XX, Payne CD, Cui CS, Lee JD, Rosengren KJ, Woodruff TM, Clark RJ. Development of Synthetic Human and Mouse C5a: Application to Binding and Functional Assays In Vitro and In Vivo. ACS Pharmacol Transl Sci 2021; 4:1808-1817. [PMID: 34927012 PMCID: PMC8669711 DOI: 10.1021/acsptsci.1c00199] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/17/2021] [Indexed: 11/28/2022]
Abstract
The complement activation peptide C5a is a key mediator of inflammation that is associated with numerous immune disorders. C5a binds and activates two seven-transmembrane receptors, C5aR1 and C5aR2. Experimentally, C5a is utilized to investigate C5a receptor biology and to screen for potential C5aR1/C5aR2 therapeutics. Currently, laboratory sources of C5a stem from either isolation of endogenous C5a from human serum or most predominantly via recombinant expression. An alternative approach to C5a production is chemical synthesis, which has several advantages, including the ability to introduce non-natural amino acids and site-specific modifications whilst also maintaining a lower probability of C5a being contaminated with microbial molecules or other endogenous proteins. Here, we describe the efficient synthesis of both human (hC5a) and mouse C5a (mC5a) without the need for ligation chemistry. We validate the synthetic peptides by comparing pERK1/2 signaling in CHO-hC5aR1 cells and primary human macrophages (for hC5a) and in RAW264.7 cells (for mC5a). C5aR2 activation was confirmed by measuring β-arrestin recruitment in C5aR2-transfected HEK293 cells. We also demonstrate the functionalization of synthetic C5a through the introduction of a lanthanide chelating cage to facilitate a screen for the binding of ligands to C5aR1. Finally, we verify that the synthetic ligands are functionally similar to recombinant or native C5a by assessing hC5a-induced neutrophil chemotaxis in vitro and mC5a-mediated neutrophil mobilization in vivo. We propose that the synthetic hC5a and mC5a described herein are valuable alternatives to recombinant or purified C5a for in vitro and in vivo applications and add to the growing complement reagent toolbox.
Collapse
Affiliation(s)
- Declan
M. Gorman
- School
of Biomedical Sciences, The University of
Queensland, Brisbane, Queensland 4072, Australia
| | - Xaria X. Li
- School
of Biomedical Sciences, The University of
Queensland, Brisbane, Queensland 4072, Australia
| | - Colton D. Payne
- School
of Biomedical Sciences, The University of
Queensland, Brisbane, Queensland 4072, Australia
| | - Cedric S. Cui
- School
of Biomedical Sciences, The University of
Queensland, Brisbane, Queensland 4072, Australia
| | - John D. Lee
- School
of Biomedical Sciences, The University of
Queensland, Brisbane, Queensland 4072, Australia
| | - K. Johan Rosengren
- School
of Biomedical Sciences, The University of
Queensland, Brisbane, Queensland 4072, Australia
| | - Trent M. Woodruff
- School
of Biomedical Sciences, The University of
Queensland, Brisbane, Queensland 4072, Australia
- Queensland
Brain Institute, The University of Queensland, Brisbane, Queensland 4072, Australia
| | - Richard J. Clark
- School
of Biomedical Sciences, The University of
Queensland, Brisbane, Queensland 4072, Australia
- Institute
for Molecular Bioscience, The University
of Queensland, Brisbane, Queensland 4072, Australia
| |
Collapse
|
5
|
Rowley JA, Reid RC, Poon EKY, Wu KC, Lim J, Lohman RJ, Hamidon JK, Yau MK, Halili MA, Durek T, Iyer A, Fairlie DP. Potent Thiophene Antagonists of Human Complement C3a Receptor with Anti-Inflammatory Activity. J Med Chem 2020; 63:529-541. [PMID: 31910011 DOI: 10.1021/acs.jmedchem.9b00927] [Citation(s) in RCA: 14] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
Abstract
Structure-activity relationships for a series of small-molecule thiophenes resulted in potent and selective antagonism of human Complement C3a receptor. The compounds are about 100-fold more potent than the most reported antagonist SB290157. A new compound JR14a was among the most potent of the new antagonists in vitro, assessed by (a) inhibition of intracellular calcium release (IC50 10 nM) induced in human monocyte-derived macrophages by 100 nM C3a, (b) inhibition of β-hexosaminidase secretion (IC50 8 nM) from human LAD2 mast cells degranulated by 100 nM C3a, and (c) selectivity for human C3aR over C5aR. JR14a was metabolically stable in rat plasma and in rat liver microsomes and efficacious in rats when given orally to suppress rat paw inflammation, macrophage and mast cell activation, and histopathology induced by intraplantar paw administration of a C3aR agonist. Potent C3aR antagonists are now available for interrogating C3a receptor activation and suppressing C3aR-mediated inflammation in mammalian physiology and disease.
Collapse
|